STELLA-FTD: Examination of a Behavior Change Intervention for FTD Family Care Partners
Oregon Health and Science University · with National Institute on Aging (NIA) · NCT06613204
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–100 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 640
- US sites recruiting
- 1
- Study start
- June 23, 2025
- Record last updated
- October 27, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The purpose of this nationwide study is to test STELLA-FTD (Support via Telehealth: Living and Learning with Advancing Alzheimer's Disease)-FTD, an intervention to specifically address the needs of family Care Partners of persons with frontotemporal degeneration (FTD). STELLA-FTD is a multicomponent videoconference-based intervention designed to facilitate effective use of community and peer resources to foster effective management of behavioral and psychological symptoms of dementia. The study is recruiting families from across the United States.
Being studied: STELLA-FTD Control; STELLA-FTD Test
Conditions: Frontotemporal Dementia; Caregiver Burden; Primary Progressive Aphasia (PPA); Corticobasal Syndrome
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria: Family Care Partner
- Adult caring for family member with FTD.
- Provides 4 or more hours of care/week. Does not have to reside with.
- Identifies at least 2 moderately upsetting behaviors in the person with FTD.
- Speaks and understands English to be able to participate in intervention.
- Owns a telephone (smartphone, cell phone or landline).
- Has email and mailing address to receive computer, study materials and surveys.
- Provides informed consent to participate in the research.
- Lives in the US
Inclusion Criteria: Person with FTD
- Diagnosis of FTD
- Family member of a Care Partner (this can be a relative, spouse, or close kin that is considered family).
- Lives in US
Exclusion Criteria: Person with FTD
- No Frontotemporal Degeneration diagnosis.
- Unable to leave Care Partner during STELLA-FTD sessions.
- Enrolled in hospice.
Exclusion Criteria: Family Care Partner
- Unable to find activity for Care Recipient during STELLA-FTD sessions to allow Care Partner to work privately with Guide and other Care Partners.
- Hearing and/or vision problems severe enough to prevent participation.
- Refuses to be video-recorded during STELLA-FTD sessions.
- Unwilling or unable to adequately follow study instructions and participate in study procedures.
Recruiting US locations
Oregon Health & Science University
Portland, OR 97239
Site contact: Hailey Chatterton, MS · 503-568-9725 · chatterton@ohsu.edu
Study contacts (from the official record)
- Hailey Chatterton, MS · 503-568-9725 · chatterton@ohsu.edu
- Allison Lindauer, PhD, APRN · 503-494-6976 · lindauer@ohsu.edu
Similar studies in Oregon
All neurology studies in Oregon →- RecruitingHealthy volunteers
Home Sleep Therapy for Older Adults With MCI
Brain Electrophysiology Laboratory Company
- Location
- Eugene, OR
- Eligibility basics
- Ages 40–85
- RecruitingPhase 1/Phase 2
A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome
Encoded Therapeutics
- Location
- Portland, OR + 9 other US sites
- Eligibility basics
- Ages 6 mo–17
- RecruitingPhase 2
A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease
Sanofi
- Location
- Portland, OR + 9 other US sites
- Eligibility basics
- Ages 55–85
- RecruitingPhase 2/Phase 3
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
Biohaven Therapeutics Ltd.
- Location
- Portland, OR + 24 other US sites
- Eligibility basics
- Ages 40–80